Autolus Therapeutics (AUTL) Operating Margin Growth (5y) (2023 - 2026)

Autolus Therapeutics (AUTL) Operating Margin Growth (5y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Autolus Therapeutics 763.37 Mn 561.74 Mn 25.22 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 240,724.00
Dec 31, 2025 1.14 Mn
Sep 30, 2025 941,275.00
Jun 30, 2025 1.32 Mn
Mar 31, 2025 1.07 Mn
Mar 31, 2024 115,176.00
Sep 30, 2023 817,266.00